These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 4005120)

  • 21. Concentration-effect relationships for oxprenolol in patients with essential hypertension.
    McInnes GT; Brodie MJ
    Br J Clin Pharmacol; 1988 May; 25(5):539-45. PubMed ID: 3408634
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Concentration-effect relationship of oxprenolol in healthy volunteers: a retrospective analysis.
    Racine-Poon A; Moppert J
    Br J Clin Pharmacol; 1985; 19 Suppl 2(Suppl 2):143S-149S. PubMed ID: 4005116
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oros controlled-release formulations of metoprolol: an approach to the development of a system for once daily administration.
    Good W; Leeson LJ; Zak SL; Wagner WE; Meeker JB; Arnold JD
    Br J Clin Pharmacol; 1985; 19 Suppl 2(Suppl 2):231S-238S. PubMed ID: 4005128
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relative bioavailability of different oral sustained release oxprenolol tablets.
    Leucuta SE; Follidis M; Capalneanu R; Mocan A
    Eur J Drug Metab Pharmacokinet; 1998; 23(2):178-84. PubMed ID: 9725478
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro and in vivo deconvolution assessment of drug release kinetics from oxprenolol Oros preparations.
    Langenbucher F; Mysicka J
    Br J Clin Pharmacol; 1985; 19 Suppl 2(Suppl 2):151S-162S. PubMed ID: 4005117
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Slow release oxprenolol in angina pectoris: study comparing oxprenolol, once daily, with propranolol, four times daily.
    Olowoyeye JO; Thadani U; Parker JO
    Am J Cardiol; 1981 May; 47(5):1123-7. PubMed ID: 7223659
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetic and pharmacodynamic comparison of an osmotic release oral metoprolol tablet and the metoprolol conventional tablet.
    Feliciano NR; Bouvet AA; Redalieu E; Castellana J; Luders RC; Schwartz DJ; Shum L; Zak S; Arnold JD; Leese PT
    Am Heart J; 1990 Aug; 120(2):483-9. PubMed ID: 2382633
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of oxprenolol dosage time on its pharmacokinetics and haemodynamic effects during exercise in man.
    Koopmans R; Oosterhuis B; Karemaker JM; Wemer J; van Boxtel CJ
    Eur J Clin Pharmacol; 1993; 44(2):171-6. PubMed ID: 8453962
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of different preparations of oxprenolol on diurnal variations of non-steady-state exercise performance in patients with coronary heart disease evaluated by computer assisted ergospirometry.
    Reiterer W
    Arzneimittelforschung; 1980; 30(7):1147-53. PubMed ID: 7191298
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of the activity and plasma levels of oxprenolol, slow release oxprenolol, long acting propranolol and sotalol.
    Leahey WJ; Neill JD; Varma MP; Shanks RG
    Eur J Clin Pharmacol; 1980 Jun; 17(6):419-24. PubMed ID: 7398733
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The pharmacokinetics and dynamics of oxprenolol: a simulation study with six subjects.
    Saunders L; Ingram D; Warrington SJ
    J Pharm Pharmacol; 1985 Nov; 37(11):802-6. PubMed ID: 2867161
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of oxprenolol and metoprolol Oros systems in the dog: comparison of in vivo and in vitro drug release, and of drug absorption from duodenal and colonic infusion sites.
    Fara JW; Myrback RE; Swanson DR
    Br J Clin Pharmacol; 1985; 19 Suppl 2(Suppl 2):91S-95S. PubMed ID: 4005134
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of the pharmacodynamic and pharmacokinetic profiles of single and multiple doses of a commercial slow-release metoprolol formulation with a new Oros delivery system.
    Kendall MJ; Jack DB; Woods KL; Laugher SJ; Quarterman CP; John VA
    Br J Clin Pharmacol; 1982 Mar; 13(3):393-8. PubMed ID: 7059440
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A comparison of slow release oxprenolol with conventional oxprenolol in the treatment of hypertension.
    Resnekov EB; Havard CW
    Eur J Clin Pharmacol; 1978 Nov; 14(2):77-81. PubMed ID: 363434
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bioavailability of conventional and slow-release oxprenolol in fasted and nonfasted individuals.
    Dawes CP; Kendall MJ; Welling PG
    Br J Clin Pharmacol; 1979 Mar; 7(3):299-302. PubMed ID: 427007
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Osmotic delivery systems for the beta-adrenoceptor antagonists metoprolol and oxprenolol: design and evaluation of systems for once-daily administration.
    Theeuwes F; Swanson DR; Guittard G; Ayer A; Khanna S
    Br J Clin Pharmacol; 1985; 19 Suppl 2(Suppl 2):69S-76S. PubMed ID: 4005132
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gastrointestinal transit of Oros drug delivery systems in healthy volunteers: a short report.
    John VA; Shotton PA; Moppert J; Theobald W
    Br J Clin Pharmacol; 1985; 19 Suppl 2(Suppl 2):203S-206S. PubMed ID: 4005123
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Controlled release metoprolol formulations. A review of their pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and ischaemic heart disease.
    Plosker GL; Clissold SP
    Drugs; 1992 Mar; 43(3):382-414. PubMed ID: 1374320
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A single and multiple dose pharmacokinetic and pharmacodynamic comparison of conventional and slow-release metroprolol.
    Kendall MJ; John VA; Quarterman CP; Welling PG
    Eur J Clin Pharmacol; 1980 Feb; 17(2):87-92. PubMed ID: 7371709
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CNS-related performance and haemodynamics of metoprolol-Oros and propranolol after single and 3 days dosing in healthy volunteers.
    van Steveninck AL; Pieters MS; Schoemaker HC; Breimer DD; Cohen AF
    Br J Clin Pharmacol; 1993 Feb; 35(2):114-20. PubMed ID: 8443028
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.